Nautilus Biotechnolgy, Inc. (NAUT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Nautilus Biotechnolgy, Inc. (NAUT) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

NAUT Cash Flow Statement

Nautilus Biotechnolgy, Inc. (NAUT) cash flow statement — 8-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-13.73M	-13.1M	-12.38M	-11.03M	-13.35M	-13.94M	-14.31M	-13.11M	-15.46M	-16.27M	-13.9M	-11.74M	-13.55M	-12.52M	-10.38M	-9.56M	-13.53M	-12.34M	-10.52M	-14.18M
Operating CF Margin %	-7224.21%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-2.82%	6.01%	13.52%	15.85%	13.63%	14.32%	-2.94%	-11.71%	-14.08%	-29.88%	-33.95%	-22.72%	-0.15%	-1.53%	1.35%	32.53%	4.9%	-97.27%	-122.53%	-320.56%
Net Income	-14.47M	-14.7M	-13.78M	-13.57M	-15.03M	-16.61M	-17.59M	-16.45M	-18.01M	-18.73M	-17.02M	-15.88M	-15.81M	-14.96M	-13.41M	-14.06M	-14.69M	-15.76M	-16.69M	-14.5M
Depreciation & Amortization	1.28M	1.48M	1.59M	1.62M	1.63M	1.63M	1.55M	1.61M	1.6M	1.59M	1.59M	1.48M	1.46M	1.17M	921K	860K	829K	806K	869K	734K
Stock-Based Compensation	1.16M	1.36M	1.47M	1.5M	1.71M	2.17M	3.12M	3.18M	3.28M	3.11M	3.07M	3.11M	3.1M	2.86M	2.83M	2.87M	2.57M	2.11M	2.53M	2.25M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-627.55K	0	0	0	0	0	0	0	0
Other Non-Cash Items	52K	-68K	-134K	-306K	-439K	-541K	216K	-723K	-702K	-751K	-619K	-449	-743K	-669K	-550K	-193K	-173K	26K	130K	-23K
Working Capital Changes	-1.75M	-1.17M	-1.52M	-269K	-1.22M	-576K	-1.61M	-740K	-1.62M	-1.49M	-920K	179K	-1.56M	-921K	-172K	961K	-2.06M	486K	2.64M	-2.63M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-304K	200K	2K	-20K	80K	-131K	-543K	273K	-402K	94K	371K	221K	-252K	53K	289K	-207K	-249K	-394K	374K	162K
Cash from Investing	12.02M	14.23M	787K	452K	14.47M	19.51M	37.11M	-7.5M	14.29M	22.35M	-41.06M	13.07M	-2.25M	-13.49M	-64.06M	-11.94M	35.08M	15.18M	6.06M	-83.98M
Capital Expenditures	-454K	-510K	-244K	-418K	-396K	-219K	-254K	-709K	-512K	-647K	-413K	-874K	-463K	-692K	-229K	-963K	-651K	-481K	-986K	-270K
CapEx % of Revenue	238.95%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	-13.95K	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	-11.13M	0	0	0	-760K	0	0	0	0	13.95K	0	0	0	0	0	0	0	0
Cash from Financing	244K	1.1M	101K	0	95K	18K	440K	140K	319K	245K	253K	16K	98K	1K	135K	86K	185K	156K	63K	11K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	244K	1.1M	101K	0	95K	18K	440K	140K	319K	245K	253K	16K	98K	1K	135K	86K	185K	156K	63K	11K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Change in Cash	-1.46M	2.24M	-11.49M	-10.58M	1.22M	5.59M	23.24M	-20.48M	-844K	6.33M	-54.71M	1.35M	-16.37M	-26.02M	-74.41M	-21.42M	21.73M	3M	-4.62M	-98.15M
Free Cash Flow	-14.18M	-13.61M	-12.62M	-11.45M	-13.75M	-14.16M	-14.56M	-13.82M	-15.97M	-16.91M	-14.31M	-12.61M	-14.01M	-13.22M	-10.61M	-10.53M	-14.18M	-12.82M	-11.51M	-14.45M
FCF Margin %	-7463.16%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-3.16%	3.86%	13.35%	17.15%	13.92%	16.3%	-1.75%	-9.59%	-13.97%	-27.97%	-34.95%	-19.79%	1.18%	-3.12%	7.81%	27.13%	6.95%	-90.29%	-128.68%	-297.66%
FCF per Share	-0.11	-0.11	-0.10	-0.09	-0.11	-0.11	-0.12	-0.11	-0.13	-0.14	-0.11	-0.10	-0.11	-0.11	-0.08	-0.08	-0.11	-0.10	-0.09	-0.12
FCF Conversion (FCF/Net Income)	0.95x	0.89x	0.90x	0.81x	0.89x	0.84x	0.81x	0.80x	0.86x	0.87x	0.82x	0.74x	0.86x	0.84x	0.77x	0.68x	0.92x	0.78x	0.63x	0.98x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0